Brian Skorney

Stock Analyst at Baird

(1.02)
# 2143
Out of 5,386 analysts
147
Total ratings
Success rate
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
DYN Dyne Therapeutics
Maintains: Outperform
46 32
9.59 233.68% 2 Jun 18, 2025
SRPT Sarepta Therapeutics
Maintains: Outperform
60 30
17.1 75.44% 8 Jun 17, 2025
SLNO Soleno Therapeutics
Maintains: Outperform
102 105
83.24 26.14% 4 May 8, 2025
BIIB Biogen
Maintains: Outperform
300 255
125.95 102.46% 16 May 2, 2025
REGN Regeneron Pharmaceut...
Maintains: Neutral
652 587
520.94 12.68% 15 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 57
14.07 305.12% 3 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 55
51.02 7.8% 5 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
95 100
110.71 -9.67% 3 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
11.29 165.72% 1 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 5
n/a n/a 4 Nov 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
7.48 167.38% 5 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
3.02 727.81% 1 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 10
2.35 325.53% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
215 215
277.28 -22.46% 3 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
157 180
125.44 43.49% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
4.12 579.61% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
52 62
29.82 107.91% 4 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 2
n/a n/a 4 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 39
8.4 364.29% 3 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
280 30
n/a n/a 2 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
63
32.37 94.62% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 173
n/a n/a 8 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 150
n/a n/a 1 Jun 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 18
n/a n/a 5 May 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
280 325
441.18 -26.33% 14 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 27
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
43 55
n/a n/a 4 Oct 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
10
16.12 -37.97% 2 Aug 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
270
1.98 13536.36% 1 May 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 6
2.96 102.7% 1 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
78 100
n/a n/a 2 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101
n/a n/a 3 Nov 1, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
600 300
2.2 13536.36% 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
33 0
n/a n/a 2 Jan 30, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 14, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Aug 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 29, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 28, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Nov 8, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2016